M3 Inc
OTC:MTHRY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shenzhen Inovance Technology Co Ltd
SZSE:300124
|
CN |
|
GK Software SE
XETRA:GKS
|
DE |
|
Sinofortune Financial Holdings Ltd
HKEX:8123
|
HK |
|
Jiangsu Lihua Animal Husbandry Co Ltd
SZSE:300761
|
CN |
|
N
|
Newland Pharmaceutical Co Ltd
SZSE:301277
|
CN |
|
China Xlx Fertiliser Ltd
HKEX:1866
|
CN |
|
China Tungsten and Hightech Materials Co Ltd
SZSE:000657
|
CN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (16.2), the stock would be worth $7.47 (60% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 10.1 | $4.67 |
0%
|
| 3-Year Average | 16.2 | $7.47 |
+60%
|
| 5-Year Average | 23.5 | $10.85 |
+132%
|
| Industry Average | 8.3 | $3.82 |
-18%
|
| Country Average | 8.7 | $4 |
-14%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
$897.6B
|
/ |
Jan 2026
¥88.1B
|
= |
|
|
$897.6B
|
/ |
Mar 2026
¥92.6B
|
= |
|
|
$897.6B
|
/ |
Mar 2027
¥100B
|
= |
|
|
$897.6B
|
/ |
Mar 2028
¥110.8B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
M3 Inc
OTC:MTHRY
|
1T USD | 10.1 | 20.8 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 21.9 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
27.5B USD | 21.1 | 30.2 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.9B AUD | 78.4 | 63.3 | |
| SE |
|
Sectra AB
STO:SECT B
|
51.1B SEK | -131.6 | 95 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
5B USD | 15.4 | 43.2 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 14.8 | 18.7 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.2B CNY | -118 | -60.4 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 267.9 | -328 | |
| US |
H
|
Heartflow Inc
NASDAQ:HTFL
|
2.7B USD | 0 | 0 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
245.4B INR | 24.3 | 36.8 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.7 |
| Median | 8.7 |
| 70th Percentile | 12.2 |
| Max | 214 699 781.2 |
Other Multiples
M3 Inc
Glance View
M3 Inc. emerged from Japan in the late 1990s, rapidly morphing from a novel digital venture into a formidable player in the global medical information services arena. The company's genesis was rooted in the transformative vision of leveraging web-based platforms to bridge vast distances between healthcare professionals, providing them with timely, accurate information and resources. As the internet began revolutionizing industries, M3 Inc. seized this opportunity, focusing on creating a seamless digital environment that connected pharmaceutical companies with medical professionals. Their flagship offering, M3.com, became a pivotal platform—essentially serving as a nexus where healthcare giants could introduce their latest products and innovations to an audience of medical practitioners, facilitating informed decision-making and nurturing vital industry relationships. Reaching beyond Japanese shores, M3 Inc. strategically expanded its influence into markets in Europe, the United States, and further afield, deftly tailoring its platforms to meet diverse regulatory standards and cultural nuances. Today, its financial vitality is driven by a multifaceted business model. Primarily, M3 derives revenue from pharmaceutical companies and medical device makers who pay for advertising space and market research insights on its network, valuing the direct engagement with physicians it facilitates. Moreover, the company has smartly diversified its portfolio by incorporating online healthcare services and physician recruitment, offering a comprehensive suite of services that cater to the evolving needs of the medical community. By aligning its growth with the digital evolution of the healthcare industry, M3 Inc. continues to solidify its role as a linchpin in the health information ecosystem.